Sensitivities of noninvasive tests for central nervous system vasculitis: A comparison of lumbar puncture, computed tomography, and magnetic resonance imaging
Stone JH et al. (1994) Sensitivities of noninvasive tests for central nervous system vasculitis: A comparison of lumbar puncture, computed tomography, and magnetic resonance imaging. J Rheumatol 21: 1277-1282
Angiography-negative primary central nervous system vasculitis in children: A newly recognized inflammatory central nervous system disease
Benseler SM et al. (2005) Angiography-negative primary central nervous system vasculitis in children: A newly recognized inflammatory central nervous system disease. Arthritis Rheum 52: 2159-2167
Intracerebral calcification in a case of systemic lupus erythematosus with neurological manifestations
Anderson JR (1981) Intracerebral calcification in a case of systemic lupus erythematosus with neurological manifestations. Neuropathol Appl Neurobiol 7: 161-166
Reliability of normal findings on MR imaging for excluding the diagnosis of vasculitis of the central nervous system
Wasserman BA et al. (2001) Reliability of normal findings on MR imaging for excluding the diagnosis of vasculitis of the central nervous system. AJR Am J Roentgenol 177: 455-459
Cyclophosphamide versus methylprednisolone for the treatment of neuropsychiatric involvement in systemic lupus erythematosus
Art. No CD002265
Trevisani VF et al. (2000) Cyclophosphamide versus methylprednisolone for the treatment of neuropsychiatric involvement in systemic lupus erythematosus. Cochrane Database of Systematic Reviews, Issue 3 Art. No CD002265
Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus
Barile-Fabris L et al. (2005) Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus. Ann Rheum Dis 64: 620-625
Systemic lupus erythematosus: Emerging concepts. Part 1: Renal, neuropsychiatric, cardiovascular, pulmonary, and hematologic disease
Boumpas DT et al. (1995) Systemic lupus erythematosus: Emerging concepts. Part 1: Renal, neuropsychiatric, cardiovascular, pulmonary, and hematologic disease. Ann Intern Med 122: 940-950
Treatment-free remission in severe systemic lupus erythematosus following synchronization of plasmapheresis with subsequent pulse cyclophosphamide
Euler HH et al. (1994) Treatment-free remission in severe systemic lupus erythematosus following synchronization of plasmapheresis with subsequent pulse cyclophosphamide. Arthritis Rheum 37: 1784-1794
Serologic and clinical response to treatment of systemic vasculitis and associated autoimmune disease with intravenous immunoglobulin
Levy Y et al. (1999) Serologic and clinical response to treatment of systemic vasculitis and associated autoimmune disease with intravenous immunoglobulin. Int Arch Allergy Immunol 119: 231-238
Central nervous system involvement in systemic lupus erythematosus: A new therapeutic approach with intrathecal dexamethasone and methotrexate
Valesini G et al. (1994) Central nervous system involvement in systemic lupus erythematosus: A new therapeutic approach with intrathecal dexamethasone and methotrexate. Springer Semin Immunopathol 16: 313-321